Instead of direct effects on the vasculature, our findings suggested that the high expression of SPARCL1 by ECs during pneumonia contributes to the worsening of lung injury by driving inflammation, ultimately causing more harm than benefit. The gene discussed is SPARCL1; the disease is pneumonia.